Health Private Equity Archives - HEALTH & LIFE SCIENCES NEWS

McDermott and EY at the 2022 J.P. Morgan Healthcare Conference: European Healthcare Private Equity Forum

by McDermott Will & Emery | Jan 14, 2022 | Health Private Equity, International Health, Uncategorized

With continued growth in healthcare global investing, what role do European markets play in global and US fund portfolios and to what extent do investments benefit from a transatlantic portfolio? Sharon Lamb, Partner at McDermott, was joined by Marco Bonaiti, Vice President at Apax Partners; Tony Drabble, Partner at EY-Parthenon; Henry Elphick, Deputy Chair of the European Healthcare Private Equity Association (EHCPEA); Rohin Jain, Managing Director of H.I.G. Capital, and Dr. Stephan Rau, Partner at McDermott, to discuss the wide range of opportunities, benefits, similarities and differences in dealmaking in competitive global markets.

Below are the top takeaways for McDermott and EY at the 2022 J.P. Morgan Healthcare Conference: European Healthcare Private Equity Forum

Download the PDF here.

A FANTASTIC TIME FOR HEALTHCARE
Healthcare proved once again to be a resilient and innovative asset during the pandemic. Multiple new buyers are emerging, and they are making significant investments and large transactions across all sectors. The year ahead promises to be an active one with no signs of slowing down.

EUROPE IS INCREASINGLY ATTRACTIVE
Beyond the fact that the healthcare market in Europe is roughly a $2 trillion market, there are advantages to having a global portfolio. One of the big attractions of the European market is that it’s not just one market. Across countries and regions, the systems and stages of development are different; [...]

Continue Reading

McDermott and EY at the 2022 J.P. Morgan Healthcare Conference: Healthcare Private Equity Leaders Forum

by McDermott Will & Emery | Jan 12, 2022 | Health Private Equity, Uncategorized

During this session, leading private equity investors explored key drivers and trends across diverse industry subsectors. They examined how shifting regulations and the upcoming 2022 midterm elections may alter the deal landscape and mapped out strategies for adapting and thriving amid change. Panelists also offered their exclusive insights into emerging opportunities in health information technology (IT) and forecasted the next evolution of today’s hypercompetitive market.

Below are the top takeaways for McDermott and EY at the 2022 J.P. Morgan Healthcare Conference: Healthcare Private Equity Leaders Forum

Download the PDF here.

From a macroeconomic perspective, the US healthcare market has seen growth through the COVID-19 crisis because of unprecedented government intervention, a significant rebound in consumer spending (although with pockets of softness) and an outlook for historically high nominal growth as COVID-19’s impact recedes but price inflation takes center stage. Although healthcare spending and employment levels have largely returned to pre-pandemic levels, the spread of the Omicron variant poses a threat to this stability, and the labor supply faces serious challenges. Workforce shortages have yielded significantly higher rates of labor cost growth—particularly in post-acute care—helping to drive healthcare inflation. While rising inflation will not necessarily inhibit healthcare deal activity, if corporate interest rates increase, healthcare investments could be affected.

In this current economic environment, investors are paying attention to entities and innovations with the potential to relieve constraints on the healthcare system. Prominent [...]

Continue Reading

HPE New York 2021: The Need for Speed

by McDermott Will & Emery | Oct 26, 2021 | Health Private Equity

In today’s supercharged private equity market, being a buyer is a tricky position. It’s tough to win deals and even more challenging to get them signed and closed on sellers’ extremely tight deadlines. Krist Werling, partner and co-head of the Private Equity Practice Group at McDermott, was joined by industry leaders to discuss these issues and the dynamics facing those on the buy side of healthcare private equity. The panel included:

Paige Daly, Partner, Harvest Partners
Sean Dempsey, Partner, Sheridan Capital Partners
Carmine Petrone, Managing Director, Advent International
Neel Varshney, MD, Founding Partner, Patient Square Capital

Access the full takeaways here.
Watch the session recording here.

HPE New York 2021: Big Bankers Breakfast

by McDermott Will & Emery | Oct 26, 2021 | Health Private Equity

The second year of the Biden administration and the potential ending of a world-shifting pandemic will surely shape the 2022 healthcare investing market. To gain insight on the year ahead, Curtis Lane, founder of WindRose Health Investors, hosted a panel with some of the leading voices in investment banking. Panelists joining Lane included:

Fritz Buerger, Managing Director, Healthcare, Healthcare Services, William Blair
Richard Harding, Managing Director and Head of the US Private Equity Solutions Group, Moelis & Company
Philip Pucciarelli, Partner, Perella Weinberg Partners
Geoffrey Smith, Managing Director and Co-Head of the Healthcare & Life Sciences Group, Harris Williams

Access the full takeaways here.
Watch the session recording here.

HPE New York 2021: Super Charging Sellers’ Strategies

by McDermott Will & Emery | Oct 26, 2021 | Health Private Equity

Fueled by historically low interest rates, all time high levels of committed—but unallocated—capital and impending tax reform, private equity deal volume and values have reached new, record-breaking heights, and they continue to rise during what everyone predicts will be a very strong fourth quarter. Frank Steinherr, co-head of the Private Equity Practice Group at McDermott, was joined by industry leaders to make sense of this very frothy and seller-friendly deal environment. The panel included:

Megan Preiner, Partner, Thomas H. Lee Partners
Geoff Lieberthal, Partner, Two Sigma Impact
Chris Harris, Managing Partner, FFL Partners

Access the full takeaways here.
Watch the session recording here.

HPE New York 2021: Prepare for Tomorrow

by McDermott Will & Emery | Oct 26, 2021 | Health Private Equity, Uncategorized

Kevin Miller—a partner at McDermott Will & Emery whose practice largely focuses on the securities, tax and regulatory aspects of complex transactions—moderated a panel during HPE New York 2021 that looked at how government actions will impact the market. The panel feature: